Recent studies demonstrated the presence of a cell subset with CD19+CD20-CD27+CD38+ phenotype that has the ability to secret antibody, either in peripheral blood or in cerebrospinal fluid, in patients with autoimmune disorders, such as neuromyelitis optica spectrum disorder and multiple sclerosis [20, 21]. This evidence concerns the gene CD19 and neuromyelitis optica.